Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04560166
Title Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Age Groups: adult | senior | child
Covered Countries

No variant requirements are available.